Atlas Trials

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)

Clinical trial NCT05769816 · RECRUITING

Trial details

NCT number
NCT05769816
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Hepatitis bAnti-PD-1 Antibody
Start date
2023-10-10
Primary completion
2026-12-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.